Hypercalcaemia with methotrexate pneumonitis, possible association with pulmonary granulomata [2]

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 5, 1996, Pages 715-

  Cook, N J ^b   Lake, F R ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; PIROXICAM;

AGED; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCALCEMIA; HYPOXEMIA; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LUNG GRANULOMA; PNEUMONIA; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY;

EID: 0029956536     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb02949.x     Document Type: Letter

References (4)

1. Sostman HD, Matthay RA, Putman CE, Walker Smith GJ. Methotrexate-induced pneumonitis. Medicine 1976; 55: 371-88.
2. Adams JS. Vitamin D metabolite-mediated hypercalcaemia. Endocrinol Metab Clin North Am 1989; 18: 765-78.
3. Adams JS, Gacad MA, Diz MM et al. A role for endogenous arachidonate metabolites in the regulated expression of the 25-hydroxyvitamin D-1-hydroxylation reaction in cultured alveolar macrophages from patients with sarcoidosis. J Clin Endocrinol Metab 1990; 70: 595-600.
4. Bell NH, Stern PH, Pantzer E et al. Evidence that increased circulating 1 25 dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 1979; 64: 218-25.